Pfizer is prioritising its research and development efforts in areas where we can make the biggest difference to health and social care burdens; immunology and inflammation, oncology, cardiovascular and metabolic diseases, neuroscience, pain and vaccines. Through major research efforts across multiple modalities - including small molecules, biologics and vaccines - Pfizer is developing the medical solution that will matter most to the people we serve. Specialised efforts in rare diseases also illustrate our dedication to developing and delivering innovative medicines and vaccines that will benefit patients around the world.
A critical part in the process of bringing new therapies to patients is clinical development - the study of potential new therapies in humans. Pfizer is committed to enhanced clinical and regulatory quality and compliance to build trust among key stakeholders, including patients and payers.
Pfizer clinical innovation is leading the industry in applying novel technologies, innovative partnerships and new approaches to enhance and transform clinical trials and the development of medicines.
Areas of focus include:
Real World Data
Mobile & Digital Tools
Clinical innovation seeks partners from all sectors with a shared interest in improving study start-up, enriching high-quality data collection, enhancing patient engagement, and supporting robust relationships with investigators. With hundreds of clinical trials at thousands of institutions around the world, Clinical Innovation links innovators to impact the development of new medicines for patients.
Pfizer works with innovative research partners across a range of disciplines to improve the quality, speed and productivity of clinical research. Using digital tools, new ways of collecting data and expanding access through diverse partnerships, Pfizer is developing breakthroughs that change patients’ lives faster than ever before.
External collaboration is critical to advancing our R&D strategy and expediting new medical breakthroughs. We continue to work with a broad array of organisations to connect the assets and capabilities that have the potential to speed the development of new medicines for patients.
New technologies are enabling unprecedented opportunities in the field of medicine, creating a capacity for breakthroughs that change patients’ lives. Pfizer’s Breakthrough Change Accelerator is a bold initiative towards that objective. We invite you to collaborate with us in creating a healthier tomorrow.
The Breakthrough Change Accelerator is managed by Pfizer’s Digital Innovation Lab. The Lab oversees a range of initiatives applying digital capabilities to better enable drug discovery, accelerate clinical development, enhance patient and provider engagement, and improve patient outcomes on a global scale.
If you share our passion for taking health technology to new heights, we encourage you to apply for one of our challenges.